Skip to main content
OpenTrials
Completed

NCT Number: NCT02531503

Predicting Factors for Asthma Remission in Children

The purpose of this study is to determine the predicting factors for asthma remission in children.

Completed

Looking for future studies?

Notify Me

Key information

Age range

Up to 15 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Division of Allergy and Immunology, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University

Bangkok, 10700, Thailand

About this study

Children who were diagnosed as having asthma during the period of 2004-2007 and reevaluated in 2015.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children who were diagnosed as having asthma during the period of 2004-2007.

Exclusion criteria

  • Patients who had underlying disease with chronic respiratory disease (ex. tuberculosis, bronchiectasis), primary immunodeficiency, other seriously interfering diseases
  • Medical records have been lost.

Treatment and study plan

Clinical asthma remission

Other

Clinical asthma remission was defined as having no asthma symptoms and no use of medication during the past 12 months.

Primary outcomes

  1. Number of factors associated with asthma remission

    Time frame: 18 months

Secondary outcomes

  1. Asthma remission rate

    Time frame: 18 months

Sponsors and collaborators

Lead sponsor

Mahidol University

Other

Registry information

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Aug 24, 2015
Registry last updated
Mar 22, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.